Li Hongli, Wang Yan, Xu Wenwei, Dong Lin, Guo Yan, Bi Kehong, Zhu Chuansheng
Department of Hematology, Qian Foshan Hospital affiliated with Shandong University, Jinan, China.
Acta Haematol. 2015;133(1):18-25. doi: 10.1159/000362683. Epub 2014 Jun 28.
Gene silencing associated with aberrant methylation of promoter region CpG islands is an acquired epigenetic alteration that serves as an alternative to genetic defects in the inactivation of tumor suppressor genes in human cancers. The demethylating, dose-dependent effect of arsenic trioxide (As2O3) on several tumor-related genes has already been postulated. However, whether such a demethylating effect also applies to the TMS1 gene in chronic myeloid leukemia cell line K562 cells has not been studied so far. The aim of the present study was to detect the methylation status of the TMS1 gene in K562 cells and the demethylation effect of As2O3 on TMS1 as well as TMS1 apoptosis-associated protein Bcl-2/Bax and DNA methyltransferase (DNMT) expression.
TMS1 mRNA expression in K562 cells and normal bone marrow was determined by reverse transcription (RT) polymerase chain reaction (PCR), and the DNA methylation status of the TMS1 promoter in K562 cells treated with different concentrations of As2O3 for 48 h was determined by methylation-specific PCR. RT-PCR and Western blot were used to detect TMS1 and DNMT expression. We also assessed TMS1-associated apoptosis protein Bcl-2/Bax expression by Western blot and apoptosis rates by flow cytometry using annexin V/propidium iodide double staining.
In K562 cells, TMS1 was completely methylated and both TMS1 mRNA and protein showed a low expression, but 2 μmol/l As2O3 could significantly restore the expression of the TMS1 gene both at mRNA and protein level (p < 0.01) by fully reversing DNA methylation. As2O3 decreased mRNA and protein expression of DNMT1 (p < 0.05) in a dose-dependent manner. Flow cytometry showed that in the experimental group (2 μmol/l As2O3), cell apoptosis was significantly increased compared with the control group (no As2O3; p < 0.05). In the experimental group, Western blot showed that the expression of the anti-apoptotic protein Bcl-2 was significantly decreased; however, the proapoptotic protein Bax was markedly increased and the Bcl-2/Bax ratio was markedly reduced (p < 0.01).
As2O3 could restore the expression of TMS1 by inhibiting DNMT to reverse the hypermethylation and induced apoptosis of K562 cells by downregulation of Bcl-2/Bax expression.
与启动子区域CpG岛异常甲基化相关的基因沉默是一种获得性表观遗传改变,在人类癌症中作为肿瘤抑制基因失活的遗传缺陷的替代机制。三氧化二砷(As2O3)对几种肿瘤相关基因的去甲基化、剂量依赖性作用已被推测。然而,这种去甲基化作用是否也适用于慢性髓系白血病细胞系K562细胞中的TMS1基因,目前尚未见研究报道。本研究旨在检测K562细胞中TMS1基因的甲基化状态以及As2O3对TMS1的去甲基化作用,以及TMS1凋亡相关蛋白Bcl-2/Bax和DNA甲基转移酶(DNMT)的表达。
采用逆转录(RT)聚合酶链反应(PCR)检测K562细胞和正常骨髓中TMS1 mRNA的表达,采用甲基化特异性PCR检测不同浓度As2O3处理48 h的K562细胞中TMS1启动子的DNA甲基化状态。采用RT-PCR和Western blot检测TMS1和DNMT的表达。我们还通过Western blot评估TMS1相关凋亡蛋白Bcl-2/Bax的表达,并使用膜联蛋白V/碘化丙啶双染法通过流式细胞术检测凋亡率。
在K562细胞中,TMS1完全甲基化,TMS1 mRNA和蛋白均低表达,但2 μmol/L As2O3可通过完全逆转DNA甲基化在mRNA和蛋白水平显著恢复TMS1基因的表达(p < 0.01)。As2O3以剂量依赖性方式降低DNMT1的mRNA和蛋白表达(p < 0.05)。流式细胞术显示,与对照组(无As2O3)相比,实验组(2 μmol/L As2O3)细胞凋亡显著增加(p < 0.05)。在实验组中,Western blot显示抗凋亡蛋白Bcl-2的表达显著降低;然而,促凋亡蛋白Bax显著增加,Bcl-2/Bax比值显著降低(p < 0.01)。
As2O3可通过抑制DNMT恢复TMS1的表达,逆转高甲基化,并通过下调Bcl-2/Bax表达诱导K562细胞凋亡。